Pentagastrin has panic-inducing properties in obsessive compulsive disorder

Psychopharmacology

Volumn 126, Issue 4, 1996, Pages 339-344

  De Leeuw, A S ^a   Den Boer, J A ^b   Slaap, B R ^b   Westenberg, H G M ^a  

^a Utrecht Universital Hospital   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

CCK B receptor; Obsessive compulsive disorder; Panic attacks; Pentagastrin; Plasma MHPG

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR AGONIST; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT; HYDROCORTISONE; PENTAGASTRIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOOD; OBSESSION; PANIC; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

EID: 0029816247     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02247385     Document Type: Article

References (29)

1. Abelson JL, Nesse RM (1990) Cholecystokinin-4 and panic. Arch Gen Psychiatry 47:395
2. Abelson JL, Nesse RM (1994) Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular responses. Biol Psychiatry 36:73-83
3. Abelson JL, Nesse RM, Vinik AI (1994) Pentagastrine infusions in patients with panic disorder II. Neuroendocrinology. Biol Psychiatry 36:84-96
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th rev. American Psychiatric Press, Washington, DC
5. Bastani B, Nash F, Meltzer HY (1990) Prolactin and cortisol responses to MK-212 a serotonin agonist, in obsessive-compulsive disorder. Arch Gen Psychiatry 47:833-839
6. Bradwejn J, Koszycki D, Meterissian G (1990) Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83-85
7. Bradwejn J, Koszycki D, Shriqui C (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Arch Gen Psychiatry 48:603-610
8. Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751-763
9. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45:177-185
10. Cowley DS, Hyde TS, Dager SR, Dunner DL (1987): Lactate infusion: the role of baseline anxiety. Psychiatry Res 21:169-179
11. de Montigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatry 46:511-517
12. Den Boer JA, Westenberg HGM, Klompmakers AA, van Lint LEM (1989) Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety. Biol Psychiatry 26:612622
13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989) The Yale-Brown obsessive compulsive scale 1. Development, use, and reliability. Arch Gen Psychiatry 46: 1006-1011
14. Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JH, Charney DS, Heninger GR (1995) m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry 38:138-149
15. Gorman JM, Liebowitz MR, Fyer AJ, Dillon D, Davies SO, Stein J, Klein DF (1985) Lactate infusions in obsessive-compulsive disorder. Am J Psychiatry 142:864-866
16. Hollander E, Decaria C, Nitescu A, Cooper T, Stover B, Gully R, Klein DF, Liebowitz MR (1991) Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Res 37:161-177
17. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR (1992) Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49:21-28
18. Koszycki D, Cox BJ, Bradwejn J (1993) Anxiety sensitivity and response to cholecystokinin in healthy volunteers. Am J Psychiatry 150:1881-1883
19. 2-adrenoreceptor status in obsessive-compulsive disorder. Biol Psychiatry 27:1083-1093
20. 1a receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. Arch Gen Psychiatry 48:540-547
21. Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G (1985) Lactate provocation of panic attacks. II Biochemical and physiological findings. Arch Gen Psychiatry 42:709-719
22. McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK (1992) Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder. Biol Psychiatry 31:1934
23. McNair DM, Lorr M, Droppelman LF (1971) Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego, Calif.
24. Nair NP, Lal S, Thavundayil JX, Etienne P, Guyda H (1984) CCK-33 antagonizes apomorphine-induced growth hormone secretion and increases basal prolactin levels in man. Neuropeptides 4:281-291
25. Pigott TA, Hill JL, Grady TA, L'Heureux F, Bernstein S, Rubenslein CS, Murphy DL (1993) A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to iv mCPP. Biol Psychiatry 33:3-14
26. Rasmussen SA, Goodman WK, Woods SW, Heninger GR, Charney DS (1987) Effects of yohimbine in obsessive compulsive disorder. Psychopharmacology 93:308-313
27. Thijssen JHH, Van den Berg JHM, Adlercreutz J (1980) Determination of Cortisol in human plasma evaluation and comparison of seven assays. Clin Chem Acta 100:39-46
28. Van Megen HJGM, Westenberg HGM, Den Boer JA, Haigh JRM, Traub M (1994) Pentagastrine induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacol 114:449-455
29. Zohar J, Mueller HA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946-951